Stockscreener 앱 받기
80.14
1.12%
-0.91
시간 외 거래:
80.14
전일 마감가:
$81.05
열려 있는:
$80.56
하루 거래량:
505.75K
Relative Volume:
0.68
시가총액:
$4.40B
수익:
$1.43B
순이익/손실:
$107.13M
주가수익비율:
41.37
EPS:
1.9372
순현금흐름:
$161.04M
1주 성능:
+2.49%
1개월 성능:
-2.54%
6개월 성능:
+21.96%
1년 성능:
+89.95%
1일 변동 폭
$79.29
$81.78
1주일 범위
$78.31
$82.70
52주 변동 폭
$41.02
$85.27
Livanova Plc Stock (LIVN) Company Profile
명칭
Livanova Plc
전화
4402033250662
주소
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
80.14 | 4.43B | 1.43B | 107.13M | 161.04M | 1.9372 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-19 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-05-20 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 개시 | Goldman | Buy |
| 2024-09-17 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 재확인 | Needham | Buy |
| 2024-02-20 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-04-14 | 개시 | Mizuho | Neutral |
| 2022-12-21 | 개시 | Barclays | Equal Weight |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-02-24 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-03 | 개시 | Goldman | Buy |
| 2021-08-20 | 재확인 | Needham | Buy |
| 2021-07-20 | 업그레이드 | Needham | Hold → Buy |
| 2021-03-03 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-01-05 | 다운그레이드 | Needham | Buy → Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-06-26 | 재확인 | Needham | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-02-28 | 재확인 | Needham | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-08 | 개시 | Stifel | Buy |
| 2018-05-31 | 재확인 | Needham | Buy |
| 2018-02-28 | 재확인 | Needham | Buy |
모두보기
Livanova Plc 주식(LIVN)의 최신 뉴스
LIVN|LivaNova PLC|Price:80.640|Chg%:+2.450 - TradingKey
LivaNova PLC (LIVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LivaNova PLC (LIVN) Balance Sheet - TradingKey
LivaNova (NASDAQ:LIVN): A Strong Growth Stock with a Constructive Technical Setup - ChartMill
LivaNova PLC (LIVN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LivaNova PLC (LIVN) Institutional Confidence - TradingKey
LivaNova PLC (LIVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LIVN|LivaNova PLC|Price:78.190|Chg%:-0.420 - TradingKey
LivaNova PLC (LIVN) Cash Flow - TradingKey
LivaNova PLC (LIVN) Income Statement - TradingKey
LivaNova PLC (LIVN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LivaNova PLC (LIVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LivaNova PLC Revenue Breakdown – NASDAQ:LIVN - TradingView
LivaNova PLC (LIVN) Stock Forecasts - Yahoo Finance
LIVN6033156 Bond Coupon Profile — Rate & Payments - TradingView
LivaNova PLC (LIVN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
LIVN6033156 Bond Risk Profile - TradingView
LIVN6033156 Bond Profile — Key Metrics - TradingView
LivaNova PLC (LIVN) Stock forecasts - Yahoo Finance UK
LivaNova (NASDAQ:LIVN) Fits the Affordable Growth Profile with Strong Earnings and Relative Value - ChartMill
(LIVN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
LivaNova PLC at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Q1 2020 LivaNova PLC Earnings Call Transcript - GuruFocus
Q3 2025 LivaNova PLC Earnings Call Transcript - GuruFocus
Q1 2025 LivaNova PLC Earnings Call Transcript - GuruFocus
LivaNova PLC (BSP:L2IV34) Stock Price, Trades & News - GuruFocus
LivaNova PLC (BSP:L2IV34)Valuation Measures & Financial Statistics - GuruFocus
LivaNova PLC (BSP:L2IV34) Stock Earnings Transcripts - GuruFocus
BSP:L2IV34 Equity-to-Asset: 0.48 — 11% Below Median - GuruFocus
LivaNova PLC Stock Operating Data - GuruFocus
BSP:L2IV34 Dividend: Does LivaNova PLC Pay a Dividend? - GuruFocus
LivaNova PLC (BSP:L2IV34) DCF Valuation - GuruFocus
LivaNova PLC Stock Warning Signs - GuruFocus
Jette Nygaard-Andersen joins LivaNova board as a new director - MSN
LIVN Maintains by Mizuho -- Price Target Raised to $95.00 - GuruFocus
LivaNova PLC (LIVN) Shares Fall 4.7% -- GF Value Says Still Over - GuruFocus
3 Service Sector Stocks With Pricing Power Investors Should Watch - Sahm
LivaNova appoints Anne Liddy as chief legal officer - MSN
LivaNova Q1 2026 Earnings: EPS Surpasses Estimates by 7.14% Amidst Mixed Market ReactionGross Profit Margin - dars.gov.et
World Cardiopulmonary Bypass MachineMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Price to earnings forward of LivaNova Plc – SWB:LIA - TradingView
LivaNova (LIVN) Edges Higher as Shares Test Mid-Range ResistanceSafe Entry Stocks - dars.gov.et
Price to sales forward of LivaNova PLC – NASDAQ:LIVN - TradingView
LivaNova PLC balances neuromodulation growth with cardiac surgery challenges - Ad-hoc-news.de
Enterprise value to EBITDA forward of LivaNova PLC – NASDAQ:LIVN - TradingView
LivaNova PLC (LIVN) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
LivaNova PLC focuses on neuromodulation and cardiopulmonary solutions as investors track its Nasdaq- - Ad-hoc-news.de
Enterprise value to revenue forward of LivaNova PLC – NASDAQ:LIVN - TradingView
Price to sales forward of LivaNova Plc – LSX:A14156 - TradingView
Price to book forward of LivaNova PLC – NASDAQ:LIVN - TradingView
How LivaNova’s Broad Russell Index Inclusion Will Impact LivaNova (LIVN) Investors - simplywall.st
Livanova Plc (LIVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Livanova Plc 주식 (LIVN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SCHERMERHORN TODD C | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
13,105 |
| Bianchi Francesco | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
11,270 |
| Bianchi Francesco | Director |
Jun 15 '26 |
Sale |
80.19 |
1,200 |
96,228 |
9,584 |
| PODLOGAR SUSAN M | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
6,128 |
| Barry James Christopher | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
8,404 |
| Tezel Ahmet | Chief Innovation Officer |
Jun 15 '26 |
Option Exercise |
0.00 |
2,965 |
0 |
7,122 |
| KOZY WILLIAM A | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
5,681 |
0 |
38,248 |
| Enxing Seng Stacy | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
15,793 |
| Story Brooke | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
10,274 |
| Zurbay Donald | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
2,560 |
0 |
2,560 |
1.04%
11.95%
자본화:
|
볼륨(24시간):